Evanko Brian C 4
4 · Cigna Group · Filed Jun 26, 2024
Insider Transaction Report
Form 4
Evanko Brian C
See Remarks
Transactions
- Exercise/Conversion
Employee Stock Option (Right to Buy)
2024-06-25−1,011→ 0 totalExercise: $120.89From: 2016-02-25Exp: 2025-02-25→ Common Stock, $.01 Par Value (1,011 underlying) - Exercise/Conversion
Common Stock, $.01 Par Value
2024-06-24$120.89/sh+4,795$579,692→ 44,718 total - Sale
Common Stock, $.01 Par Value
2024-06-24$345.01/sh−4,795$1,654,303→ 39,923 total - Exercise/Conversion
Common Stock, $.01 Par Value
2024-06-25$120.89/sh+1,011$122,225→ 40,934 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2024-06-24−4,795→ 1,011 totalExercise: $120.89From: 2016-02-25Exp: 2025-02-25→ Common Stock, $.01 Par Value (4,795 underlying)
Holdings
- 883.159(indirect: By 401(k))
Common Stock, $.01 Par Value
Footnotes (4)
- [F1]These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2024.
- [F2]Represents the weighted average price of the shares sold. The prices actually received ranged from $345.00 to $345.07 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
- [F3]Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.
- [F4]This option was granted on February 25, 2015. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.